TrialInternational journal of clinical oncology2022

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.

Thomas John et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.